In pulmonary fibrosis, sinensetin can activate GSK-3β to reduce pulmonary fibrosis15, but inhibition of GSK-3β can also improve pulmonary fibrosis16, 17. This evidence concerns the gene GSK3B and pulmonary fibrosis.